心脑舒通胶囊治疗脑血栓形成后遗症的临床效果  

Clinical effect of Xinnaoshutong capsules in the treatment of cerebral thrombosis sequela

作　　者：杜宝奎 

机构地区：[1]海拉尔区人民医院,021000

出　　处：《中国实用医药》2015年第5期29-30,共2页China Practical Medicine

摘　　要：目的观察心脑舒通胶囊治疗脑血栓形成后遗症的临床效果。方法 106例脑血栓形成后遗症患者随机分为治疗组(60例)与对照组(46例),对照组仅给予常规疗法,治疗组在对照组基础上加用心脑舒通胶囊治疗,观察两组的治疗效果。结果治疗组神经功能缺损程度评分与日常生活活动能力指数(Barthel)评分改善效果显著优于对照组(P<0.05);治疗组与对照组总有效率分别为93.33%与73.91%,组间比较差异具有统计学意义(χ2=14.706,P=0.000)。结论心脑舒通胶囊治疗脑血栓形成后遗症临床疗效满意,建议在本疾病患者中推广使用。Objective To observe the clinical effect of Xinnaoshutong capsules in the treatment of cerebral thrombosis sequela. Methods A total of 160 cerebral thrombosis sequela patients were randomly divided into treatment group（n=60） and control group（n=46）. The control group received conventional treatment alone, while the treatment group was treated by additional Xinnaoshutong capsules. The curative effects of the two groups were observed. Results The neural function defect score and activities of daily living index（Barthel） score were all improved obviously in the treatment group than the control group（P〈0.05）. The total effective rates were 93.33% and 73.91% in the treatment group and control group respectively. The difference between the two groups had statistical significance（χ^2=14.706, P=0.000）. Conclusion Xinnaoshutong capsules can provide satisfactory clinical effect in treating cerebral thrombosis sequela, and it is recommended for promotion and application in patients with this disease.

关 键 词：脑血栓形成 后遗症 心脑舒通胶囊 

分 类 号：R743.3[医药卫生—神经病学与精神病学]